Aims Despite the well-documented short-to-medium-term effectiveness of e-Health
(electronic health) secondary prevention interventions on patients with cardiovascular …

Background: Secondary prevention lifestyle and pharmacological treatment of
atherosclerotic cardiovascular disease (ASCVD) reduce a high proportion of recurrent …

Background Previous studies have shown that women with acute coronary syndrome (ACS)
are less likely to receive in-hospital care such as revascularisation procedures and …

Aims People in remote areas may have more difficulty accessing healthcare following
myocardial infarction (MI) than people in metropolitan areas. We determined whether …

Aims We determined the prevalence of prescription smoking cessation pharmacotherapy
(SCP) use after hospitalization for major cardiovascular disease (MCD) among people who …

Objectives To compare secondary prevention care for patients with coronary heart disease
(CHD) and stroke, exploring particularly the influences due to frequency and regularity of …

Objectives The risk of adverse events and prognostic factors are changing in different time
phases after acute myocardial infarction (AMI). The incidence of adverse events is …

Objective To describe baseline socio-demographic and clinical characteristics and drugs
prescribed for secondary prevention after a first episode of ACS and to assess differences …

Background: Acute coronary syndrome (ACS) patients are widely treated with long-term beta-
blocker therapy after cardiac event. Especially for low-risk patients, the benefits of beta …

Objective There is a rising burden of myocardial infarction (MI) within sub-Saharan Africa.
Prospective studies of detailed MI outcomes in the region are lacking. Methods Adult …